MED LIFE S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.1 RON | +1.80% |
|
+10.15% | +28.14% |
| May. 10 | Med Life S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 03 | Med Life S.A. (BVB:M) acquired an unknown majority stake in Personal Genetics Srl. | CI |
| Sales 2024 * | 2.49B 544M | Sales 2025 * | 2.78B 607M | Capitalization | 2.71B 592M |
|---|---|---|---|---|---|
| Net income 2024 * | 22M 4.81M | Net income 2025 * | 30M 6.55M | EV / Sales 2024 * | 1.09 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.97 x |
| P/E ratio 2024 * |
128
x | P/E ratio 2025 * |
85
x | Employees | 6,997 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.39% |
More Fundamentals
* Assessed data
More news
Latest transcript on Med Life S.A.
| 1 day | +1.80% | ||
| 1 week | +10.15% | ||
| 1 month | +23.49% | ||
| 3 months | +30.43% | ||
| 6 months | +24.69% | ||
| Current year | +28.14% |
1 week
4.59
5.23
1 month
4.115.23
Current year
3.835.23
1 year
3.835.23
3 years
3.366.50
5 years
1.106.50
10 years
0.966.50
| Managers | Title | Age | Since |
|---|---|---|---|
Mihail Marcu
CEO | Chief Executive Officer | 53 | 06-07-31 |
Adrian Lungu
DFI | Director of Finance/CFO | - | - |
Dorin Preda
DFI | Director of Finance/CFO | 48 | 07-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ovidiu Fer
BRD | Director/Board Member | 40 | 20-11-30 |
| Director/Board Member | 68 | 17-08-31 | |
Dorin Preda
DFI | Director of Finance/CFO | 48 | 07-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 112 M€ | +4.61% | - | |
| 0.00% | 45 M€ | -.--% | - | |
| 0.00% | 7 M€ | +5.36% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 5.1 | +1.80% | 459,404 |
| 24-05-30 | 5.01 | -3.65% | 251,924 |
| 24-05-29 | 5.2 | +5.91% | 512,808 |
| 24-05-28 | 4.91 | +4.47% | 1,387,843 |
| 24-05-27 | 4.7 | +1.51% | 365,424 |
End-of-day quote Bucharest S.E., May 30, 2024
More quotes
MedLife S.A. specializes in medical diagnosis and treatment services for enterprises and individuals. The group is active in the fields of orthopedics and traumatology, general and plastic surgery, spinal surgery, gynecology, paediatrics and maternity services.
At the end of 2021, MedLife S.A. operated 80 clinics, 11 multi- and mono-disciplinary hospitals, 34 medical laboratories (near 200 sampling centres), 17 dental clinics and 22 pharmacies located in Romania.
Calendar
2024-08-29
- Q2 2024 Earnings Call
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
5.1
RON
Average target price
4.983
RON
Spread / Average Target
-2.29%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +28.14% | 590M | |
| +25.52% | 88.99B | |
| -24.52% | 74.82B | |
| -5.56% | 25.03B | |
| +4.31% | 17.88B | |
| -14.25% | 16.43B | |
| +2.97% | 15.77B | |
| +70.11% | 13.09B | |
| +79.20% | 13.21B | |
| +40.44% | 12.9B |
- Stock Market
- Equities
- M Stock
